Tryp Therapeutics Appoints Dr. Robin Carhart-Harris to Scientific Advisory Board Post published:February 2, 2021 Post category:Press Release
Red Light Holland Announces the Red Light Holland “Give-You-A-Job” Contest Post published:February 1, 2021 Post category:Press Release
PharmaTher Signs Exclusive Worldwide License Agreement for Patented Microneedle Delivery Technology to Deliver Ketamine Post published:February 1, 2021 Post category:Press Release
Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies Post published:February 1, 2021 Post category:Press Release
Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange Post published:February 1, 2021 Post category:Press Release
Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule” Post published:February 1, 2021 Post category:Press Release
Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts Post published:January 29, 2021 Post category:Press Release
Psychedelic Bulletin: Psychedelics ETF Launches; atai Collaborate with Mass General; McGill Publishes LSD Research Post published:January 29, 2021 Post category:Psychedelic Bulletin
Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility Post published:January 29, 2021 Post category:Press Release
Red Light Holland Announces Closing of $9.77 Million Bought Deal Financing Post published:January 28, 2021 Post category:Press Release